| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,381 |
21,008 |
$5.35M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,931 |
15,362 |
$2.72M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,298 |
7,777 |
$2.07M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,978 |
1,880 |
$785K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
884 |
660 |
$670K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
5,505 |
5,317 |
$521K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,204 |
2,126 |
$472K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
404 |
390 |
$401K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,700 |
5,073 |
$375K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,055 |
8,451 |
$374K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,311 |
1,266 |
$356K |
| 71045 |
Radiologic examination, chest; single view |
5,428 |
5,053 |
$325K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,308 |
5,709 |
$325K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,074 |
6,561 |
$292K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,405 |
18,343 |
$231K |
| 80053 |
Comprehensive metabolic panel |
17,579 |
16,169 |
$227K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,607 |
2,498 |
$220K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,784 |
1,662 |
$220K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,237 |
1,095 |
$207K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,024 |
1,981 |
$205K |
| 71046 |
Radiologic examination, chest; 2 views |
2,961 |
2,841 |
$172K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,816 |
1,344 |
$168K |
| 49083 |
|
459 |
243 |
$151K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
272 |
268 |
$142K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,933 |
1,821 |
$137K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,445 |
2,220 |
$136K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,465 |
1,425 |
$130K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,284 |
1,229 |
$129K |
| 81001 |
|
12,930 |
11,884 |
$115K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,274 |
1,076 |
$110K |
| 36415 |
Collection of venous blood by venipuncture |
23,905 |
20,911 |
$93K |
| 74018 |
|
1,181 |
1,144 |
$91K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,629 |
3,551 |
$87K |
| 73562 |
|
844 |
809 |
$83K |
| 84484 |
|
3,996 |
3,292 |
$74K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
457 |
226 |
$71K |
| 72100 |
|
835 |
827 |
$70K |
| 73610 |
|
755 |
727 |
$70K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,130 |
2,097 |
$65K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,639 |
6,265 |
$61K |
| 87634 |
|
973 |
955 |
$60K |
| 86141 |
|
3,308 |
3,156 |
$56K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
252 |
245 |
$54K |
| 73030 |
|
565 |
550 |
$47K |
| 83880 |
|
1,882 |
1,664 |
$46K |
| 73630 |
|
708 |
678 |
$43K |
| 87650 |
|
1,150 |
1,123 |
$43K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
655 |
628 |
$38K |
| 85610 |
|
4,236 |
3,858 |
$37K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
455 |
428 |
$37K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,168 |
3,003 |
$36K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
83 |
82 |
$34K |
| 83690 |
|
4,165 |
3,891 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
896 |
866 |
$32K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
896 |
866 |
$32K |
| G0378 |
Hospital observation service, per hour |
63 |
61 |
$30K |
| 70486 |
|
144 |
142 |
$28K |
| D7140 |
Extraction, erupted tooth or exposed root |
61 |
61 |
$28K |
| 73130 |
|
472 |
454 |
$28K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
724 |
298 |
$28K |
| 85730 |
|
2,645 |
2,420 |
$26K |
| 74022 |
|
320 |
312 |
$25K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
309 |
62 |
$25K |
| 80074 |
|
348 |
346 |
$24K |
| 81025 |
|
3,609 |
3,488 |
$24K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,187 |
1,176 |
$24K |
| 87631 |
|
249 |
235 |
$23K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,089 |
2,500 |
$22K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
38 |
38 |
$21K |
| 82553 |
|
2,269 |
2,152 |
$21K |
| 80061 |
Lipid panel |
2,008 |
1,981 |
$21K |
| 84702 |
|
1,207 |
1,008 |
$21K |
| 71250 |
|
102 |
99 |
$20K |
| 73110 |
|
287 |
282 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,931 |
1,773 |
$18K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,220 |
2,804 |
$18K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
147 |
147 |
$18K |
| 83605 |
|
908 |
794 |
$18K |
| 82550 |
|
2,360 |
2,237 |
$17K |
| 87077 |
|
1,053 |
986 |
$17K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
21 |
13 |
$17K |
| 82150 |
|
1,797 |
1,716 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
2,362 |
2,221 |
$13K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
174 |
171 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
254 |
186 |
$13K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
27 |
27 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,708 |
1,682 |
$12K |
| 87040 |
|
985 |
635 |
$12K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,287 |
1,786 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
57 |
57 |
$11K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
466 |
335 |
$10K |
| 83735 |
|
1,311 |
1,236 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,286 |
4,628 |
$10K |
| 84439 |
|
1,342 |
1,321 |
$9K |
| 72131 |
|
42 |
39 |
$9K |
| 85379 |
|
498 |
465 |
$9K |
| 85652 |
|
1,020 |
987 |
$7K |
| 96376 |
|
323 |
283 |
$7K |
| 76801 |
|
97 |
90 |
$7K |
| 82962 |
|
3,020 |
2,221 |
$7K |
| 72040 |
|
78 |
77 |
$6K |
| 76770 |
|
60 |
59 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,158 |
3,655 |
$6K |
| 97032 |
|
354 |
86 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
363 |
354 |
$6K |
| 87186 |
|
735 |
686 |
$6K |
| 83540 |
|
235 |
234 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
13 |
12 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
49 |
49 |
$6K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
12 |
$6K |
| D2330 |
|
12 |
12 |
$6K |
| 86780 |
|
351 |
346 |
$5K |
| 76536 |
|
42 |
42 |
$5K |
| 87070 |
|
215 |
206 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
154 |
53 |
$5K |
| 93971 |
|
51 |
50 |
$5K |
| 86900 |
|
447 |
429 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,605 |
2,299 |
$4K |
| 81003 |
|
2,134 |
2,047 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
168 |
73 |
$4K |
| 86901 |
|
448 |
430 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,855 |
1,782 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
13 |
$4K |
| 90715 |
|
274 |
268 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26 |
21 |
$4K |
| 84112 |
|
93 |
87 |
$4K |
| 85651 |
|
420 |
405 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
89 |
85 |
$4K |
| 82607 |
|
310 |
307 |
$4K |
| 86696 |
|
147 |
147 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,707 |
1,616 |
$3K |
| 84703 |
|
309 |
303 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,517 |
1,143 |
$3K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
484 |
469 |
$3K |
| 74019 |
|
24 |
24 |
$3K |
| 82731 |
|
31 |
27 |
$3K |
| 84481 |
|
255 |
251 |
$3K |
| 97010 |
|
214 |
55 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
619 |
603 |
$2K |
| 82570 |
|
298 |
260 |
$2K |
| 82728 |
|
255 |
247 |
$2K |
| 73080 |
|
27 |
25 |
$2K |
| C1769 |
Guide wire |
140 |
138 |
$2K |
| 73502 |
|
39 |
39 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,340 |
1,301 |
$2K |
| 97165 |
|
67 |
63 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
376 |
370 |
$2K |
| 82043 |
|
159 |
158 |
$2K |
| 86695 |
|
147 |
147 |
$2K |
| 99152 |
|
25 |
24 |
$2K |
| 83615 |
|
106 |
96 |
$2K |
| 82565 |
|
357 |
333 |
$2K |
| 73090 |
|
25 |
25 |
$2K |
| 85027 |
|
204 |
188 |
$2K |
| 59025 |
Fetal non-stress test |
13 |
13 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
368 |
341 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$2K |
| 73560 |
|
26 |
25 |
$1K |
| 97166 |
|
43 |
40 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
902 |
700 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
734 |
658 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
795 |
740 |
$1K |
| 86038 |
|
160 |
158 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
374 |
363 |
$1K |
| 76942 |
|
12 |
12 |
$1K |
| 76857 |
|
13 |
13 |
$1K |
| 87807 |
|
74 |
73 |
$1K |
| 12001 |
|
14 |
12 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
487 |
395 |
$998.33 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
13 |
12 |
$858.65 |
| 84550 |
|
121 |
115 |
$810.89 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
479 |
445 |
$721.76 |
| 97161 |
|
32 |
28 |
$689.64 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
222 |
175 |
$648.86 |
| 86850 |
|
87 |
87 |
$604.29 |
| 73590 |
|
13 |
12 |
$583.52 |
| A9270 |
Non-covered item or service |
1,189 |
575 |
$571.77 |
| J3490 |
Unclassified drugs |
15 |
15 |
$538.45 |
| 80050 |
General health panel |
20 |
19 |
$520.50 |
| 87205 |
|
55 |
53 |
$507.77 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
89 |
88 |
$488.03 |
| 85007 |
|
58 |
55 |
$429.07 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
235 |
215 |
$401.17 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17 |
17 |
$391.77 |
| 87081 |
|
53 |
49 |
$301.41 |
| 84153 |
|
12 |
12 |
$273.76 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
84 |
77 |
$268.49 |
| 87075 |
|
26 |
26 |
$267.48 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
106 |
101 |
$259.73 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
47 |
44 |
$218.72 |
| 83525 |
|
26 |
25 |
$215.13 |
| 84100 |
|
42 |
40 |
$201.83 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
54 |
44 |
$190.91 |
| J1644 |
Injection, heparin sodium, per 1000 units |
99 |
56 |
$180.38 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
92 |
81 |
$116.38 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
188 |
185 |
$108.66 |
| V2632 |
Posterior chamber intraocular lens |
772 |
576 |
$107.07 |
| J7510 |
Prednisolone oral, per 5 mg |
102 |
102 |
$105.04 |
| 82248 |
|
15 |
15 |
$85.64 |
| 83550 |
|
16 |
15 |
$83.44 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
136 |
128 |
$77.46 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
98 |
98 |
$73.05 |
| 82746 |
|
12 |
12 |
$61.66 |
| J2060 |
Injection, lorazepam, 2 mg |
46 |
39 |
$58.67 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
34 |
31 |
$58.46 |
| C9113 |
Injection, pantoprazole sodium, per vial |
43 |
38 |
$55.16 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
13 |
12 |
$55.16 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
14 |
14 |
$54.35 |
| J1956 |
Injection, levofloxacin, 250 mg |
13 |
13 |
$24.36 |
| A4615 |
Cannula, nasal |
40 |
39 |
$8.94 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
50 |
40 |
$0.00 |